Ischemin

CAS No. 1357059-00-7

Ischemin( —— )

Catalog No. M11461 CAS No. 1357059-00-7

A cell permeable CBP bromodomain inhibitor with Kd of 19 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ischemin
  • Note
    Research use only, not for human use.
  • Brief Description
    A cell permeable CBP bromodomain inhibitor with Kd of 19 uM.
  • Description
    A cell permeable CBP bromodomain inhibitor with Kd of 19 uM; inhibits the acetyl-lysine binding activity of CBP, inhibits p53 interaction with CBP and decreases p53 transcriptional activity; protects against doxorubicin-induced apoptosis in cardiomyocytes in vitro.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1357059-00-7
  • Formula Weight
    335.378
  • Molecular Formula
    C15H17N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=CC(=C(C=C1N=NC2=C(C=C(C(=C2)C)O)N)S(=O)(=O)O)C
  • Chemical Name
    5-[(1E)-2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-2,4-dimethylbenzenesulfonic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Borah JC, et al. Chem Biol. 2011 Apr 22;18(4):531-41.
molnova catalog
related products
  • Ischemin sodium

    A cell permeable CBP bromodomain inhibitor with Kd of 19 uM.

  • OF-1

    OF-1 is a potent bromodomain inhibitor that inhibits BRPF1B/2/3 bromodomains with Kd of 0.1/0.5/2.4 uM.

  • Mivebresib

    Mivebresib (ABBV-075) is a potent and orally available BET bromodomain inhibitor with Ki of 1.0, 12.2, 1.5, and 2.2 nM for BRD2, BRD3, BRD4 and BRDT, respectively.